The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Australia: TGA Restricts OTC Cough and Cold Medications
Posted 20 August 2012 | By
Australia's Therapeutic Goods Administration (TGA) has concluded that over-the-counter (OTC) cough and cold medicines registered with the agency should not be given to children under the age of six, and should be given only on the advice of health professionals for those ages six to 12.
The restrictions stem from a review of the safety and efficacy of these products conducted by the agency that found although there are no immediate safety risks associated with the products, there are potential risks for children with only limited evidence of benefits.
Products placed on the market prior to 1 September 2012, will be allowed to remain on the market, but products marketed after that date must include the revised labeling.
Read all Breaking News from RegLink